PDP1 and cancer: This was in agreement with the previously published reports that inactivation of PDKs in various cancer cell lines, either by the small molecule inhibitor DCA [55] or molecular (siRNA) approaches [97], leads to increased activity of PDH, thereby changing cellular bioenergetics and restoring mitochondria‐dependent apoptosis [98, 99].